We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+17.67%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.3B
AUM Growth
+$1.6B
Cap. Flow
+$186M
Cap. Flow %
1.65%
Top 10 Hldgs %
53.18%
Holding
660
New
44
Increased
183
Reduced
381
Closed
52

Sector Composition

Rank Sector Weight
1 Energy 69.1%
2 Materials 2.16%
3 Healthcare 1.94%
4 Financials 1.94%
5 Technology 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
201
Alphabet (Google) Class A
GOOGL
$3.91T
$1.21M 0.01%
34,460
+23,100
+203% +$848K
SLG icon
202
SL Green Realty
SLG
$3.93B
$1.2M 0.01%
11,678
-469
-4% -$46.1K
PDLI
203
DELISTED
PDL BioPharma, Inc.
PDLI
$1.16M 0.01%
368,094
+37,187
+11% +$124K
UDR icon
204
UDR
UDR
$12.8B
$1.11M 0.01%
30,169
-598
-2% -$21.4K
SCMP
205
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$1.1M 0.01%
100,201
+10,723
+12% +$120K
KDNY
206
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.03M 0.01%
18,153
+3,932
+28% +$239K
ENLC
207
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$964K 0.01%
+60,564
New +$864K
REG icon
208
Regency Centers
REG
$15B
$921K 0.01%
11,003
+17
+0.2% +$1.31K
ENTA icon
209
Enanta Pharmaceuticals
ENTA
$376M
$910K 0.01%
41,273
+4,273
+12% +$112K
INSM icon
210
Insmed
INSM
$23.2B
$857K 0.01%
+86,926
New +$1.01M
EGRX
211
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$852K 0.01%
+21,965
New +$915K
AROC icon
212
Archrock
AROC
$6.46B
$827K 0.01%
+87,755
New +$692K
EPZM
213
DELISTED
Epizyme, Inc
EPZM
$823K 0.01%
+80,387
New +$896K
VA
214
DELISTED
Virgin America Inc.
VA
$815K 0.01%
14,501
-1,500
-9% -$83.2K
INTC icon
215
Intel
INTC
$483B
$804K 0.01%
24,520
+9,822
+67% +$308K
CLVS
216
DELISTED
Clovis Oncology, Inc.
CLVS
$740K 0.01%
53,924
+10,828
+25% +$158K
DIS icon
217
Walt Disney
DIS
$165B
$722K 0.01%
7,383
+2,649
+56% +$265K
LOXO
218
DELISTED
Loxo Oncology, Inc
LOXO
$696K 0.01%
30,015
+8,437
+39% +$210K
KRC icon
219
Kilroy Realty
KRC
$4.63B
$695K 0.01%
10,486
-241
-2% -$15.2K
META icon
220
Meta Platforms (Facebook)
META
$1.53T
$695K 0.01%
6,082
+1,877
+45% +$216K
OTIC
221
DELISTED
Otonomy, Inc.
OTIC
$672K 0.01%
42,304
+9,425
+29% +$141K
AERI
222
DELISTED
Aerie Pharmaceuticals
AERI
$656K 0.01%
37,268
+7,618
+26% +$123K
MDVN
223
DELISTED
MEDIVATION, INC.
MDVN
$643K 0.01%
10,660
-784
-7% -$44.5K
AIMT
224
DELISTED
Aimmune Therapeutics
AIMT
$642K 0.01%
59,351
+11,837
+25% +$161K
DY icon
225
Dycom Industries
DY
$13.1B
$631K 0.01%
7,029
-520
-7% -$39.3K

Similar funds

ALPS Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, ALPS Advisors held 660 positions worth $11.3B, up 17% from $9.68B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

ALPS Advisors's Q2 2016 filing shows 44 new, 183 increased, 381 reduced and 52 closed positions. Its largest new stake was NGL Energy Partners: 5,895,930 shares worth $114M. The largest sale was Energy Transfer Partners L.p., an estimated $88.3M.

By sector, the portfolio is most concentrated in Energy at 69% of assets, up from 67% a quarter earlier, followed by Materials and Healthcare.

  • ALPS Advisors's largest Q2 2016 buy was NGL Energy Partners: 5,895,930 shares worth $114M.
  • ALPS Advisors added most to Magellan Midstream Partners, L.P. in Q2 2016, an estimated $132M increase.
  • ALPS Advisors's biggest Q2 2016 reduction was Energy Transfer Partners L.p., cutting an estimated $88.3M.
  • ALPS Advisors fully exited Brookfield in Q2 2016, selling an estimated $48.6M.
  • ALPS Advisors's ten largest holdings make up 53% of its $11.3B portfolio in Q2 2016.
  • ALPS Advisors opened 44 new positions and closed 52 in Q2 2016.
  • ALPS Advisors's portfolio value rose 17% quarter-over-quarter to $11.3B.

Based on ALPS Advisors's 13F filing for Q2 2016, filed 27 Jul 2016.